Kidney Allocation System (KAS) was enacted in 2014 to improve graft utility, while facilitating transplantation of highly-sensitized patients and preserving pediatric access to high-quality kidneys. Central to this system is the Kidney Donor Profile Index (KDPI), a metric intended to predict transplant outcomes based on donor characteristics but derived using only adult donors. We posited that KAS had inadvertently altered the profile and quantity of kidneys made available to pediatric recipients. This question arose from our observation that most pediatric donors carry a KDPI over 35 and have therefore been rendered relatively inaccessible to pediatric recipients under KAS. Here we explore early trends in pediatric transplantation following KAS, including: (i) use of pediatric donors, (ii) use of Public Health System (PHS) high infectious risk donors, (iii) wait time, and (iv) living donor transplantation. We note some concerning preliminary changes following KAS implementation, including the allocation of fewer deceased donor pediatric kidneys to children and stagnation in pediatric wait times.
Kidney Allocation System (KAS) was enacted in 2014 to improve graft utility, while facilitating transplantation of highly-sensitized patients and preserving pediatric access to high-quality kidneys. Central to this system is the Kidney Donor Profile Index (KDPI), a metric intended to predict transplant outcomes based on donor characteristics but derived using only adult donors. We posited that KAS had inadvertently altered the profile and quantity of kidneys made available to pediatric recipients. This question arose from our observation that most pediatric donors carry a KDPI over 35 and have therefore been rendered relatively inaccessible to pediatric recipients under KAS. Here we explore early trends in pediatric transplantation following KAS, including: (i) use of pediatric donors, (ii) use of Public Health System (PHS) high infectious risk donors, (iii) wait time, and (iv) living donor transplantation. We note some concerning preliminary changes following KAS implementation, including the allocation of fewer deceased donor pediatric kidneys to children and stagnation in pediatric wait times.
Moreover, the poor predictive power of the KDPI for adult donors appears to be even worse when applied to pediatric donors. These early trends warrant further observation and consideration of changes in pediatric kidney allocation if they persist.
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donors and donation: deceased, health services and outcomes research, kidney (allograft) function/dysfunction, kidney transplantation/nephrology, liver allograft function/dysfunction, organ allocation, organ procurement and allocation, pediatrics, risk assessment/risk stratification For these analyses, we included pre-transplant candidates continuing to accrue wait time. Medians were compared using the WilcoxonMann-Whitney test. 
| INTRODUCTION

| RESULTS
Between our study period dates of January 1, 2000 and March 31, 2016, 136 605 first-time, kidney-alone, deceased donor transplants occurred in the U.S. The cohort used for graft survival analyses (minimum 6.25 years follow-up) included 78 882 transplants. Figure 1 demonstrates the KDPIs of all donors, grouped by age. As seen, the KDPI reached its nadir at donor age 18 and trended upwards towards 100 for the very young and very old. Below age 6, no donor had a KDPI less than 35 and thus would not be prioritized for a pediatric recipient.
(1) Is KDPI a good predictor of graft survival for pediatric donor kidneys transplanted into pediatric or adult recipients?
As shown in Figure 2 , overall unadjusted graft survival was not different in recipients receiving donor kidneys age 3-17 with KDPI <35 versus ≥35 (P = .94). A sensitivity analysis stratifying by recipient age (0-10 and 11-17) again showed no difference in graft outcome among these two groups. (2) Are children receiving a similar proportion of pediatric donor kidneys since KAS adoption compared to before? Table 1 demonstrates the percentage of age-stratified pediatric donors transplanted into pediatric recipients. These data show an overall decrease in pediatric donor utilization among pediatric recipients following KAS implementation, from 13.4% to 10.1%, P = .023. Most notable is the change in the utilization of donors age 6 to 11 years for pediatric recipients, which dropped from 14.0% in the year prior to KAS, to 7.8% in the year following, although this did not reach strict statistical significance (P = .056). 
| DISCUSSION
Kidney Allocation System is the result of a comprehensive effort across more than a decade, with the goal of equitably matching donor and recipient expected outcomes and improving access to transplantation among distinct groups including highly sensitized recipients, those with blood group B, and children. Here we explore the early predictive ability of the KPDI for pediatric kidneys as well as changes in the pediatric transplant landscape since KAS.
In contrast to the competing Life Years From Transplant (LYFT)
proposal, 11 KAS sacrifices some longevity gains to maintain transplant access for older recipients. 2 However, the implementation of KAS was not intended to disadvantage children and specifically sought to maintain pediatric priority for what were felt to be "better" quality organs.
Children had previously received priority for donors less than 35 years as young donor age remains a positive predictor of successful graft outcomes. 12 Under KAS, KDPI <35% replaced age as a proxy for quality, but the application of KDPI failed to acknowledge its lack of discriminant validity in characterizing pediatric donors. Specifically, the significant weighting of height and weight in the KDPI formulation, based on the underlying assumption that lower height and weight are associated with reduced renal mass and therefore worse graft outcomes, 13 assure that almost every pediatric donor under age 10 will have a KDPI over 35%.
Our exploratory analysis found the outcomes for pediatric donors We acknowledge that these observed changes in PHS status, wait times, dialysis times and living donation are impacted by many other factors, and the causality of KAS pediatric allocation policy in these early trends is unclear. Additionally, our analyses are limited by the projection of pre-KAS outcomes into the post-KAS era. We acknowledge as well that as with any retrospective analysis, our evaluation has the inherent limitations of large national datasets and the interpretation of prior actions to predict future events.
It cannot be denied, however, that the centrality of KDPI in KAS has restricted the donor cohort available to children. This represents the flawed application of an adult donor metric to pediatric donors, for whom the KDPI was neither derived nor tested. As measures of donor and recipient quality become more sophisticated in the future, it is incumbent upon the transplant community to apply these models only to the population for which they were formulated and validated. Furthermore, KAS has limited the ability of the transplant surgeon to make customized choices for the recipients he or she knows well. There may be situations where a smaller sized kidney is desirable for a pediatric recipient 16 yet would be nearly unobtainable under KAS. KAS has functionally limited the donor pool for children without demonstrable benefit to their outcomes.
While an elegant solution might be to adopt a KDPI validated for 
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